We’d love to hear about your experiences and discuss future opportunities for clinical trials.
Contact us to set aside time to chat at the 7th AMR Conference.
Vice President,
Global Strategy
Senior Account
Development Manager,
Client Solutions
U.S.A (Headquarters)
359 Blackwell Street, Suite 200, Durham, NC 27701 USA
South Africa
121 Amkor Road, Lyttelton Manor, Centurion, 0157, SOUTH AFRICA
Kenya
Britam Towers, 24th Floor, Hospital Road, Upper Hill KENYA
Liberia
The Cape Hotel, Mamba Point, Monrovia LIBERIA
Craig McNees has over 10 years of experience in the clinical research industry. Craig’s experience ranges from project management to business development and strategic account management. Most recently, Craig managed and provided oversight to key, strategic accounts at a mid-sized CRO. Before that, he was a business development director at a larger CRO and was accountable for bringing in new business while overseeing current clients and growing and maintaining the client relationship. Craig is very passionate about creating a trusting and growth-promoting relationship with clients and team members.
Craig holds a bachelor’s degree in psychology from Pennsylvania State University. He lives in Cary, NC, with his wife and two children.
Rob King brings more than 30 years of clinical research industry experience to his role as FHI Clinical’s Chief Executive Officer. King has extensive experience in global clinical operations and executive leadership, with a professional and academic focus in quality management and compliance.
King has contributed to consistent double-digit growth at his last four organizations, and he is experienced in leading the acquisition and integration of global CRO and biotech companies. Prior to joining FHI Clinical, he held the position of COO at Asklepios Biopharmacetical, Inc (AskBio), a gene therapy biotech. While there, he oversaw corporate growth, fundraising, integrations and facility expansion to allow for development of six adeno-associated virus (AAV) investigational products.
King also held the position of COO at Novella Clinical (now IQVIA Biotech), an oncology and medical device-focused global CRO. At Novella, he was responsible for global operations and client delivery across 1,500 staff and 52 countries. Prior to joining Novella, King was COO at Health Decisions, a CRO focused on women’s health. At Health Decisions, he oversaw global operations and served as project director for the clinical and statistical coordinating center for the National Institutes of Health-sponsored Contraceptive Clinical Network.
King served for seven years as an Adjunct Professor at Campbell University, lecturing in clinical research, and he continues to serve on the Durham Technical Community College Clinical Trials Research Advisory Committee.
King holds a bachelor’s degree in psychology from the University of North Carolina at Wilmington and is certified in nonprofit management from Duke University.